CDC advisory group votes to add COVID-19 vaccines to the pediatric immunization schedule; a new report says workplaces can be hazardous to the mental and physical health of Americans; drug makers are lobbying to ease the impact of the Inflation Reduction Act.
CDC Advisory Group Votes to Add COVID-19 to Pediatric Immunization Schedule
In a unanimous 15-to-0 vote, the Advisory Committee on Immunization Practices (ACIP) approved adding the COVID-19 vaccine to the recommended immunizations for children, according to CIDRAP. States often use the immunization schedule as a guide, but not all states require the vaccines on the schedule. The recommendation came a day after ACIP approved adding vaccines for COVID-19 to a program that provides free vaccines for children who either can’t afford them or who are uninsured.
Work Can Be Hazardous to Mental and Physical Health
Workplaces can be hazardous to Americans’ mental health and well-being, as well as their physical health, according to a new report from the United States Surgeon General. According to STAT, the report drew attention to factors like racism, bullying, and powerlessness at work, which contribute to ill health. The report calls on companies to protect employees from physical harm, by implementing basic safety, and psychological harm, by protecting against harassment. In addition, the report calls for workers to have adequate time off.
Drug Makers Lobby Against Impacts of the IRA
The Inflation Reduction Act (IRA) gives Medicare the authority to negotiate drug prices for certain therapies, and drug makers are seeking to ease the impact of the law, reported The Wall Street Journal. Both the Biotechnology Innovation Organization and Pharmaceutical Research and Manufacturers of America, the 2 largest grade groups for the pharmaceutical industry, say the law threatens investment in drug development without doing enough to lower drug costs for patients. Both groups are working to limit the effect the law will have on drug research.
Hospital Stays and Probable Dementia as Predictors of Relocation to Long-Term Care Facilities
October 22nd 2024This article explores late-life relocations in patients with dementia, hospital stays, and their implications for health care policy, geriatric care, and future research priorities.
Read More
Bridging the Vaccination Gap: Insights on Global Immunization Challenges
July 30th 2024On this episode of Managed Care Cast, we speak with Jeffery A. Goad, PharmD, MPH, 2024-2025 president of the National Foundation for Infectious Diseases, on the recent report from the World Health Organization and UNICEF on public immunization rates, with national and global health implications.
Listen
Frameworks for Advancing Health Equity: Health Equity by Design
July 23rd 2024Melissa Clarke, MD, CMQ, the chief health equity officer at Elevance Health, explains "Health Equity by Design" and how Elevance Health is committed to ensuring a personalized and intentional approach for all its members.
Listen
Cost Savings From an mHealth Tool for Improving Medication Adherence
October 21st 2024The Wellth smartphone app significantly increased medication adherence and lowered unnecessary health care utilization and costs over 9 months among Medicaid beneficiaries who were self-managing chronic conditions.
Read More